Literature DB >> 6615418

Differential responses of cyclic GMP-dependent and cyclic AMP-dependent protein kinases to synthetic peptide inhibitors.

D B Glass.   

Abstract

The peptide Arg-Lys-Arg-Ala-Arg-Lys-Glu was synthesized and tested as an inhibitor of cyclic GMP-dependent protein kinase. This synthetic peptide is a non-phosphorylatable analogue of a substrate peptide corresponding to a phosphorylation site (serine-32) in histone H2B. The peptide was a competitive inhibitor of cyclic GMP-dependent protein kinase with respect to synthetic peptide substrates, with a Ki value of 86 microM. However, it did not inhibit phosphorylation of intact histones by cyclic GMP-dependent protein kinase under any conditions tested. Arg-Lys-Arg-Ala-Arg-Lys-Glu competitively inhibited the phosphorylation of either peptides or histones by the catalytic subunit of cyclic AMP-dependent protein kinase, with similar Ki values (550 microM) for both of these substrates. The peptide Leu-Arg-Arg-Ala-Ala-Leu-Gly, which was previously reported to be a selective inhibitor of both peptide and histone phosphorylation by cyclic AMP-dependent protein kinase, was a poor inhibitor of cyclic GMP-dependent protein kinase acting on peptide substrates (Ki = 800 microM), but did not inhibit phosphorylation of histones by cyclic GMP-dependent protein kinase. The selectivity of these synthetic peptide inhibitors toward either cyclic GMP-dependent or cyclic AMP-dependent protein kinases is probably based on differences in the determinants of substrate specificity recognized by these two enzymes. It is concluded that histones interact differently with cyclic GMP-dependent protein kinase from the way they do with the catalytic subunit of cyclic AMP-dependent protein kinase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615418      PMCID: PMC1152103          DOI: 10.1042/bj2130159

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase.

Authors:  B E Kemp; D J Graves; E Benjamini; E G Krebs
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

2.  Isolation and properties of the bovine brain protein inhibitor of adenosine 3':5'-monophosphate-dependent protein kinases.

Authors:  J G Demaille; K A Peters; T P Strandjord; E H Fischer
Journal:  FEBS Lett       Date:  1978-02-01       Impact factor: 4.124

Review 3.  Phosphorylation-dephosphorylation of enzymes.

Authors:  E G Krebs; J A Beavo
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

4.  Inhibition of cyclic AMP-dependent protein kinase by analogues of a synthetic peptide substrate.

Authors:  J R Feramisco; E G Krebs
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

Review 5.  Protein kinases.

Authors:  E G Krebs
Journal:  Curr Top Cell Regul       Date:  1972

6.  The amino acid sequence of a hinge region in the regulatory subunit of bovine cardiac muscle cyclic AMP-dependent protein kinase II.

Authors:  K Takio; K A Walsh; H Neurath; S B Smith; E G Krebs; K Titani
Journal:  FEBS Lett       Date:  1980-05-19       Impact factor: 4.124

7.  Synthetic hexapeptide substrates and inhibitors of 3':5'-cyclic AMP-dependent protein kinase.

Authors:  B E Kemp; E Benjamini; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

8.  Intrinsic activity of guanosine 3',5'-monophosphate-dependent protein kinase similar to adenosine 3',5'-monophosphate-dependent protein kinase. I. Phosphorylation of histone fractions.

Authors:  M Yamamoto; Y Takai; E Hashimoto; Y Nishizuka
Journal:  J Biochem       Date:  1977-06       Impact factor: 3.387

9.  Purification and characterization of catalytic subunit of skeletal muscle adenosine 3':5'-monophosphate-dependent protein kinase.

Authors:  P J Bechtel; J A Beavo; E G Krebs
Journal:  J Biol Chem       Date:  1977-04-25       Impact factor: 5.157

10.  Studies on the sites in histones phosphorylated by adenosine 3':5'-monophosphate-dependent and guanosine 3':5'-monophosphate-dependent protein kinases.

Authors:  E Hashimoto; M Takeda; Y Nishizuka; K Hamana; K Iwai
Journal:  J Biol Chem       Date:  1976-10-25       Impact factor: 5.157

View more
  7 in total

1.  Modulation of hybrid bass retinal gap junctional channel gating by nitric oxide.

Authors:  C Lu; D G McMahon
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

2.  Protein kinase involvement in land snail aestivation and anoxia: protein kinase A kinetic properties and changes in second messenger compounds during depressed metabolism.

Authors:  S P Brooks; K B Storey
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

3.  Nitric oxide depresses GABAA receptor function via coactivation of cGMP-dependent kinase and phosphodiesterase.

Authors:  E M Wexler; P K Stanton; S Nawy
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

4.  Human Organic Solute Transporter (hOST): protein interaction and membrane sorting process.

Authors:  An-Qiang Sun; Libin Zhu; Yuhuan Luo; Shuhua Xu; Jing Lin; Frederick J Suchy
Journal:  Int J Biochem Mol Biol       Date:  2012-09-25

5.  Electron capture dissociation mass spectrometric analysis of lysine-phosphorylated peptides.

Authors:  Karolina Kowalewska; Piotr Stefanowicz; Tomasz Ruman; Tomasz Fraczyk; Wojciech Rode; Zbigniew Szewczuk
Journal:  Biosci Rep       Date:  2010-12       Impact factor: 3.840

6.  Membrane trafficking of the human organic anion-transporting polypeptide C (hOATPC).

Authors:  An-Qiang Sun; Vijaya M Ponamgi; James L Boyer; Frederick J Suchy
Journal:  Pharm Res       Date:  2007-07-20       Impact factor: 4.200

7.  Presynaptically localized cyclic GMP-dependent protein kinase 1 is a key determinant of spinal synaptic potentiation and pain hypersensitivity.

Authors:  Ceng Luo; Vijayan Gangadharan; Kiran Kumar Bali; Rou-Gang Xie; Nitin Agarwal; Martina Kurejova; Anke Tappe-Theodor; Irmgard Tegeder; Susanne Feil; Gary Lewin; Erika Polgar; Andrew J Todd; Jens Schlossmann; Franz Hofmann; Da-Lu Liu; San-Jue Hu; Robert Feil; Thomas Kuner; Rohini Kuner
Journal:  PLoS Biol       Date:  2012-03-13       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.